Yahoo Web Search

Search results

    • Donanemab’s solid day

      Politico· 3 days ago

      “mRNA-1083 showed an acceptable tolerability and safety profile,” the company said in a press release. “The majority of solicited adverse reactions were grade 1 or 2 in severity and consistent ...